PRJNA262495
Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer (ATC) cell lines and their genomic evolution over a year as a primagraft
Context: Anaplastic thyroid cancer (ATC) has no effective treatment, resulting in high rate of mortality. We established cell lines from a primary ATC and its lymph node metastasis, and investigated the molecular factors and genomic changes associated with tumor growth.  Objective: The aim of the study was to understand the molecular and genomic changes of highly aggressive ATC and its clonal evolution to develop rational therapies.  Design: We established unique cell lines from primary (OGK-P) and metastatic (OGK-M) ATC specimen, as well as primagraft from the metastatic ATC which was serially xeno-transplanted for more than one year in NSG mice were established. These cell lines and primagraft were used as tools to examine gene expression, copy number changes and somatic mutations using RNA array, SNP Chip and whole exome sequencing.